Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01741454 · ClinicalTrials.gov registry record · Phase 4
Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 181
- Enrollment target
NCT01741454 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 181 participants.
The verdict
NCT01741454, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 181 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether combination therapy with Tolterodine ER and Tamsulosin is more effective than monotherapy with tamsulosin alone in reducing stent symptoms. The second purpose is to determine if people have less stent discomfort if they take these medications starting 2 weeks before the stent is placed The investigators hope to show that the addition of Tolterodine ER to Tamsulosin will provide added benefits in reducing stent symptoms in patients who have had unilateral placement of a ureteral stent.
Interventions
- DRUG Tamsulosin
- DRUG Tolterodine ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2012-11 |
| Est. Completion | 2018-03-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01741454
The ClinicalTrials.gov registry entry for NCT01741454 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tamsulosin is the first listed.
NCT01741454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01741454 about?
NCT01741454 is a clinical study titled "Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction". The purpose of this study is to determine whether combination therapy with Tolterodine ER and Tamsulosin is more effective than monotherapy with tamsulosin alone in reducing stent symptoms. The second purpose is to determine if people have less stent discomfort if they take these medications startin...
What is the current status of trial NCT01741454?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 181 participants. The study started on 2012-11. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT01741454?
The interventions under investigation include: Tamsulosin (DRUG), Tolterodine ER (DRUG).
Who is sponsoring clinical trial NCT01741454?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.